Short versus long duration of dual antiplatelet therapy following drug-eluting stents: a meta-analysis of randomised trials

BACKGROUND: Dual antiplatelet therapy (DAPT) remains the cornerstone therapy in the prevention of ischaemic events following drug-eluting stent (DES) implantation. Mandatory duration of DAPT after DES however, is a matter of debate. We aimed to evaluate safety and efficacy of short-term (up to 6 mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozemeijer, R., Voskuil, M., Greving, J. P., Bots, M. L., Doevendans, P. A., Stella, P. R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2018
Materias:
Original Article - E‑Learning
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910311/
https://www.ncbi.nlm.nih.gov/pubmed/29541996
http://dx.doi.org/10.1007/s12471-018-1104-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910311/
https://www.ncbi.nlm.nih.gov/pubmed/29541996
http://dx.doi.org/10.1007/s12471-018-1104-6

Ejemplares similares